Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Naloxone Knowledge, Carrying, Purchase, and Use

View through CrossRef
ImportanceWidespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provided by community organizations, hospitals, and clinics, or sold over-the-counter.ObjectiveTo estimate naloxone knowledge, carrying, purchase, and use among US adults.Design, Setting, and ParticipantsThis survey study included noninstitutionalized adults aged 18 years and older from a national sample and a sample self-reporting opioid dependence. Respondents answered online questions between June 7 and June 29, 2024, about naloxone knowledge, carrying, purchase, and use.ExposuresOpioid misuse, risk of overdose, risk of overdose by person known to respondent.Main Outcomes and MeasuresNaloxone knowledge, prevalence of naloxone carrying, purchase, and administration.ResultsThe survey included 1515 individuals from a national sample (median [IQR] age, 45 [33-58] years; 770 women [50.8%]; 215 Black [14.2%], 1087 White [71.8%]) and 512 who self-reported opioid dependence. In the national sample, 50 respondents (3.3%) reported opioid dependence, yielding 562 respondents reporting opioid dependence (median [IQR] age, 41 [35-48] years; 404 female [70.2%]; 17 Black [3.0%], 494 White [87.9%]). Overall, 1164 respondents—700 (46.2%) in the national sample and 500 (89.0%) reporting opioid dependence—had heard of naloxone and correctly identified its purpose. One hundred sixty participants (10.6%) in the national sample and 340 participants (60.5%) in the sample reporting opioid dependence reported carrying naloxone. Among those reporting they were “very likely to overdose,” 22 respondents (31.0%) in the national sample and 31 (73.8%) with opioid dependence reported carrying naloxone. Among those who know someone very likely to overdose, 43 participants (25.4%) in the national sample and 190 participants (70.1%) reporting opioid dependence reported carrying naloxone. Among those who ever carried naloxone, 108 (42.4%) in the national sample and 97 (22.6%) reporting opioid dependence had ever purchased naloxone. Overall, 128 respondents (8.4%) in the national sample and 267 respondents (47.5%) reporting opioid dependence reported administering naloxone to someone else while 93 (6.1%) in the national sample and 221 (39.3%) reporting opioid dependence reported being administered naloxone.Conclusions and RelevanceIn this survey study of naloxone, most respondents reporting opioid dependence correctly identified naloxone’s purpose and carried it. Most naloxone carried was not purchased, suggesting a need for new ways, including rapid online surveys, to monitor naloxone possession.
American Medical Association (AMA)
Title: Naloxone Knowledge, Carrying, Purchase, and Use
Description:
ImportanceWidespread naloxone access is a key policy response to the opioid crisis.
Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provided by community organizations, hospitals, and clinics, or sold over-the-counter.
ObjectiveTo estimate naloxone knowledge, carrying, purchase, and use among US adults.
Design, Setting, and ParticipantsThis survey study included noninstitutionalized adults aged 18 years and older from a national sample and a sample self-reporting opioid dependence.
Respondents answered online questions between June 7 and June 29, 2024, about naloxone knowledge, carrying, purchase, and use.
ExposuresOpioid misuse, risk of overdose, risk of overdose by person known to respondent.
Main Outcomes and MeasuresNaloxone knowledge, prevalence of naloxone carrying, purchase, and administration.
ResultsThe survey included 1515 individuals from a national sample (median [IQR] age, 45 [33-58] years; 770 women [50.
8%]; 215 Black [14.
2%], 1087 White [71.
8%]) and 512 who self-reported opioid dependence.
In the national sample, 50 respondents (3.
3%) reported opioid dependence, yielding 562 respondents reporting opioid dependence (median [IQR] age, 41 [35-48] years; 404 female [70.
2%]; 17 Black [3.
0%], 494 White [87.
9%]).
Overall, 1164 respondents—700 (46.
2%) in the national sample and 500 (89.
0%) reporting opioid dependence—had heard of naloxone and correctly identified its purpose.
One hundred sixty participants (10.
6%) in the national sample and 340 participants (60.
5%) in the sample reporting opioid dependence reported carrying naloxone.
Among those reporting they were “very likely to overdose,” 22 respondents (31.
0%) in the national sample and 31 (73.
8%) with opioid dependence reported carrying naloxone.
Among those who know someone very likely to overdose, 43 participants (25.
4%) in the national sample and 190 participants (70.
1%) reporting opioid dependence reported carrying naloxone.
Among those who ever carried naloxone, 108 (42.
4%) in the national sample and 97 (22.
6%) reporting opioid dependence had ever purchased naloxone.
Overall, 128 respondents (8.
4%) in the national sample and 267 respondents (47.
5%) reporting opioid dependence reported administering naloxone to someone else while 93 (6.
1%) in the national sample and 221 (39.
3%) reporting opioid dependence reported being administered naloxone.
Conclusions and RelevanceIn this survey study of naloxone, most respondents reporting opioid dependence correctly identified naloxone’s purpose and carried it.
Most naloxone carried was not purchased, suggesting a need for new ways, including rapid online surveys, to monitor naloxone possession.

Related Results

Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Abstract Patients with sickle cell disease (SCD) are known to require increased dosing of drugs including opioids due to differences in renal and hepatic metabolism....
Naloxone Improves Splanchnic Perfusion in Conscious Dogs through Effects on the Central Nervous System
Naloxone Improves Splanchnic Perfusion in Conscious Dogs through Effects on the Central Nervous System
Background In patients undergoing colonoscopy, naloxone has vasodilative properties. However, it remains unclear whether this effect is mediated by central or p...
Pharmacists’ naloxone offering and dispensing practices
Pharmacists’ naloxone offering and dispensing practices
Objective: The primary objective of this paper is to understand pharmacists’ naloxone offering and dispensing practices and factors affecting those practices. The secondary objecti...
Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis
Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis
Objectives: Pruritus may be a significant problem for patients in the postoperative period. There are many options for the treatment of pruritus including intravenous (IV) naloxone...
Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person
Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person
Objective: To determine whether a pharmacist-led intervention would increase the number of naloxone prescriptions and naloxone administration education in a primary care family med...
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Objective: To compare naloxone doses and clinical outcomes after emergency opioid reversal in opioid-naïve and opioid-tolerant inpatients.Design: Cross-sectional, retrospective cha...
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones
Abstract We have recently demonstrated the existence of a neuromodulatory regulation of prolactin secretion by the opioid system showing a paradoxical opioid-indu...

Back to Top